AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201511-02-2019
11-02-2019
Aarti Drugs Q3 net dips 10% at Rs 20.89 cr
Drug firm Aarti Drugs on Monday reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore for the quarter ended December 31, 2011-02-2019
AARTI DRUGS LTD. - 524348 - Audited Financial Results (Standalone & Consolidated) For The Quarter & Nine Months Ended 31St December, 2018.
Audited Financial Results (Standalone & Consolidated) for the Quarter & Nine months ended 31st December, 2018.11-02-2019
Aarti Drugs Ltd - 524348 - Closure of Trading Window
Closure of Trading Window pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015.02-02-2019
Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve Statement of Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2018.02-02-2019
AARTI DRUGS LTD. - 524348 - Shareholding for the Period Ended December 31, 2018
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here17-01-2019
AARTI DRUGS LTD. - 524348 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Aarti Drugs Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.14-01-2019
Aarti Drugs Ltd - 524348 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Aarti Drugs Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.11-01-2019
Aarti Drugs Ltd - 524348 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1670 Name of the Signatory :- Vibhav S. RanadeDesignation :- Company Secretary and Compliance Officer10-01-2019
AARTI DRUGS LTD. - 524348 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Aarti Drugs Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.24-12-2018